Aurora Cannabis (ACB) Cash from Discontinued Operations (2018 - 2026)
Aurora Cannabis (ACB) posted quarterly Cash from Discontinued Operations of 9410000.0 for Q1 2026, down 1128.6% year-over-year from 914833.97 in Q1 2025, and down 198.88% quarter-over-quarter from 9517000.0 in Q4 2025.
Aurora Cannabis (ACB) Cash from Discontinued Operations (2018 - 2026) Analysis & Trends
Aurora Cannabis (ACB) has reported Cash from Discontinued Operations for 9 consecutive years, with 9410000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Discontinued Operations fell 1128.6% year-over-year to 9410000.0; the TTM figure through Mar 2026 stood at 28180088.79 (up 143.83% YoY), while the FY2026 annual figure was 4144075.95, down 186.99% from the prior year.
- Cash from Discontinued Operations retreated to 9410000.0 in Q1 2026 per ACB's latest filing, from 9517000.0 in the prior quarter.
- Across five years, Cash from Discontinued Operations topped out at 28839000.0 in Q4 2024 and bottomed at 30882000.0 in Q3 2023.
- Historically, Cash from Discontinued Operations has averaged 3547598.9 across 5 years, with a median of 4333234.88 in 2022.
- Annual changes were most pronounced in 2022 — Cash from Discontinued Operations tumbled 1864.71% — and 2024, when it surged 647.85%.
- Aurora Cannabis' Cash from Discontinued Operations stood at 7811997.98 in 2022, then surged by 32.62% to 5264000.0 in 2023, then soared by 647.85% to 28839000.0 in 2024, then slumped by 67.0% to 9517000.0 in 2025, then plunged by 198.88% to 9410000.0 in 2026.
- Business Quant data shows ACB's Cash from Discontinued Operations at 9410000.0 in Q1 2026, 9517000.0 in Q4 2025, and 765911.21 in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Aurora Cannabis | 243.01 Mn | 170.70 Mn | 25.75 Mn | -7.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.41 Mn |
| Mar 31, 2026 | -9.41 Mn |
| Dec 31, 2025 | 9.52 Mn |
| Dec 31, 2025 | 9.52 Mn |
| Mar 31, 2025 | -765,911.21 |
| Mar 31, 2025 | -765,911.21 |
| Dec 31, 2024 | 28.84 Mn |
| Dec 31, 2024 | 28.84 Mn |
| Sep 30, 2024 | -24.89 Mn |
| Sep 30, 2024 | -24.89 Mn |
| Jun 30, 2024 | 8.38 Mn |
| Jun 30, 2024 | 8.38 Mn |
| Mar 31, 2024 | -457,141.74 |
| Mar 31, 2024 | -457,141.74 |
| Dec 31, 2023 | -5.26 Mn |
| Dec 31, 2023 | -5.26 Mn |
| Sep 30, 2023 | -30.88 Mn |
| Sep 30, 2023 | -30.88 Mn |
| Dec 31, 2022 | -7.81 Mn |
| Dec 31, 2022 | -7.81 Mn |